Furthermore, clinical expression analysis demonstrated a substantial correlation between the diseased stage and the differential expression of ARL3 (pT, pN, and pTNM) in COAD patients (Figure S1 and Table S1). The gene discussed is ARL3; the disease is colon adenocarcinoma.